The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Azenta has also announced plans to sell B Medical (TASE: PMCN) Systems, a move expected to be well-received by the investment community. This strategic shift is reflected in the company's fiscal year ...

Greetings, and welcome to the Azenta Second Quarter 2024 Financial Results. [Operator Instructions] As a reminder, this conference is being recorded, Wednesday, March 8 [May 8], 2024. I will now turn ...

Azenta, Inc. is a Massachusetts headquartered company that is focused on the development and marketing of comprehensive biological and chemical compound sample management and genomic solutions. These ...

Azenta Life Sciences is a pharmaceutical company that specializes in developing and commercializing innovative therapies for the treatment of cancer. The company's lead product candidate is a novel ...

Azenta’s Q4 non-GAAP EPS of $0.21 exceeded expectations by 10.53%. Revenue growth of 6% year-over-year to $159 million. Stock price increased by 13.43% in pre-market trading. Strong performance in the ...